Skip to main content
Clinical Trials/ACTRN12622000521729
ACTRN12622000521729
Not yet recruiting
未知

The effect of cerebellar transcranial direct current stimulation on ataxia in people with SCA1: A pilot randomised cross-over trial

Auckland University of Technology0 sites10 target enrollmentApril 1, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Auckland University of Technology
Enrollment
10
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2022
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Ten participants aged between 18 and 70 with confirmed SCA1 will be recruited through the Neurogenetics Research Clinic.
  • confirmed genetic test
  • independently mobile with or without walking aids (able to walk 10m)
  • able to give consent,

Exclusion Criteria

  • do not have any medical conditions such as epilepsy, unexplained recurring headaches and cardiac arrhythmias which may influence the results
  • do not have history of epilepsy, head injury or concussion in the last six months
  • do not have a skull fracture or other known skull defects
  • do not have any metal implants or pacemakers
  • do not have migraine headaches or Meniere’s disease

Outcomes

Primary Outcomes

Not specified

Similar Trials